1102 - Unravelling Prognostic Significance: Long-Read Nanopore Sequencing of TP53 and IGHV in Chronic Lymphocytic Leukaemia Patients in Tanzania.

Primary Author / Presenter(s)

Collin R. Nzunda, BSc, MPhil

Research Scientist
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Dar es Salaam, Tanzania

Co-Author(s)

EB

Eliud Buchard, BSc, MPhil

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
JB

Jeffer Bhuko, BSc, MPhil

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
HC

Heavenlight Christopher, BSc, MPhil

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
ES

Emmanuel Saukiwa, BSc, MSc

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
CM

Caro Mollel, MD

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
RS

Rehema Shungu, BSc

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
CC

Clara Chamba, MD, MMED, PhD

Muhimbili University of Health and Allied Science
Muhimbili University of Health and Allied Services
Dar Es Salaam, Dar es Salaam, Tanzania
HD

Helene Dreau, BSc, MSc

Principal Clinical Scientist
Oxford University
Oxfordshire, England, United Kingdom
WM

William Mawalla, MD, MMED

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
Anna Schuh, MD, PhD

Professor
Churchill Hospital, Oxford University
Oxford, England, United Kingdom
AC

Antony Cutts, BSc, PhD

Oxford University
Oxfordshire, England, United Kingdom
AN

Ahlam Nasser, MD, MMED, PhD

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania
AB

Adam Burns, BSc, PhD

Oxford University
Oxfordshire, England, United Kingdom
DK

Doreen Kamori, MD, PhD

Muhimbili University of Health and Allied Science
Dar Es Salaam, Dar es Salaam, Tanzania